OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/21/2026
Back to search
Official data from USPTO
OXFORD BIOMEDICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OXFORD BIOMEDICA
ST13
US500000079411188Class
40
Filing
79411188
Registration
7989064
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/22/2026
Trademark type
Word
Nice classes
40
Filing date
06/18/2024
Registration date
10/21/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2025
Last transaction
05/22/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
24
Owner location
Oxford, Oxfordshire, GB
Examiner
CORWIN, CHARLOTTE K
Current location
Historical data usage
Holders and representatives
Holders
Oxford BioMedica plc
Representatives
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of products relating to biotechnology; custom manufacture of gene therapyviralretrovirallentiviral and non-viral preparations and biopharmaceutical products; custom manufacturing services for biotechnological products; custom manufacturing services for viral and non-viral vectors; custom manufacture of vaccines.
Publications
History of USPTO decisions and trademark events.
29 publications found
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
05/14/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/04/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/30/2026
FIMP
FINAL DISPOSITION PROCESSED
04/30/2026
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
03/03/2026
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
02/12/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/09/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/21/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
10/29/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/21/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/21/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/02/2025
PUBO
PUBLISHED FOR OPPOSITION
09/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/27/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/30/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/30/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/30/2025
RFNT
REFUSAL PROCESSED BY IB
02/22/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/05/2025
RFRR
REFUSAL PROCESSED BY MPU
02/05/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/31/2024
CNRT
NON-FINAL ACTION WRITTEN
12/30/2024
DOCK
ASSIGNED TO EXAMINER
12/19/2024
MAFR
APPLICATION FILING RECEIPT MAILED
12/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/06/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/05/2024
Continuous trademark protection
Get notified about every new filing that threatens OXFORD BIOMEDICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.